Keywords: ریفامپین; Rifampicin; Potentiometry; Carbon paste electrodes; Determination; Drug analysis;
مقالات ISI ریفامپین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ریفامپین; Tuberculosis; Intensive phase; Continuous phase; Piperine; Rifampicin;
Keywords: ریفامپین; Campylobacter jejuni; Oxidative stress; Antimicrobial resistance; MarR domain; T6SS; Type VI Secretion System; gDNA; Genomic DNA; BA; Blood agar; CI; Confidence Intervals; S; Sensitive; R; Resistant; HR; Highly resistant; HTH; Helix-turn-helix; RIF; Rifam
Keywords: ریفامپین; Rifampicin; Polymethylmethacrylate; Microcapsules; Cement spacers; Periprosthetic infection; Rifampicina; Polimetilmetacrilato; Microcápsulas; Espaciadores de cemento; Infección periprotésica;
Keywords: ریفامپین; Rifampicin; Conformational polymorphism; Crystalline structure; Zwitterion; Charge transfer;
Keywords: ریفامپین; Eletrooxidation; Fenton reaction; DSA; BDD; Rifampicin;
Keywords: ریفامپین; Rifampicin; Honey; Alginate; Cellulose nanocrystals; Drug delivery; Biocompatibility;
Keywords: ریفامپین; Intranasal; Rifampicin; Aβ oligomers; Hepatotoxicity; Pharmacokinetics; Prevention; Alzheimer's disease;
Keywords: ریفامپین; Rifampicin; Rifampin; Tuberculosis; High dose rifampicin; Dry powder inhaler;
Keywords: ریفامپین; Stem cell therapy; Mesenchymal stem cells; Rifampicin; Tuberculosis; Histopathology; Kidney;
Keywords: ریفامپین; Alzheimer's disease; Amyloid β-protein; Oligomers; Oligomeropathy; Aβ; amyloid β-protein; AD; Alzheimer's disease; ADDL; Aβ-derived diffusible ligands; AFM; atomic force microscopy; APP; Aβ precursor protein; APP OSK mice; APP transgenic mice express
Keywords: ریفامپین; ALG; alginate; Cm; capreomycin; CHI; chitosan; DPIs; dry powder inhalers; E; ethambutol; EC; ethyl cellulose; ECM; extracellular matrix; Eto; ethionamide; FPF; fine particle fraction; HA; hyaluronic acid; HIP/PCA; hydrophobic ion-pairing/precipitation wit
Keywords: ریفامپین; Inos; Isoprinosine; INH; Isoniazid; RIF; Rifampicin; PYZ; Pyrazinamide; ETH; Ethambutol; CFU; Colony Forming Units;
Keywords: ریفامپین; ACC; aminocyclopropane-1-carboxylic acid; 2; arbuscular mycorrhizal fungi; CFU; colony forming units; Cm; chloramphenicol; HLB; huanglongbing; LB; lysogeny brot; MS; murashige and Skoog salt solution; ONPG; ortho-nitrophenyl-β-galactoside; PGPR; plant gr
Keywords: ریفامپین; tuberculosis; fixed dose combination; isonicotinyl hydrazone; isoniazid; pyrazinamide; rifampicin; ethambutol dihydrochloride;
Keywords: ریفامپین; Nickel nanoparticles; Nickel hexacyanoferrates (NiHCF); Rifampicin; Voltametric sensor; Analytical application;
Keywords: ریفامپین; Lipid; Nanoparticles; Cubosome; Antibacterial; Rifampicin; MIC; Cytotoxicity;
Keywords: ریفامپین; Clindamycin phosphate; Rifampicin; Bioanalytical method; Skin permeation; HPLC;
Keywords: ریفامپین; Kanamycin; Rifampicin; Hydrophobic; High dose; Spray-drying; Surface;
Keywords: ریفامپین; ABC; ATP-Binding cassette; ARPE-19; human retinal pigment epithelial cells; BBB; blood-brain barrier; BCRP; breast cancer resistant protein; CNS; central nervous system; 3D-QSAR; 3-Dimensional Quantitative Structure Activity; ELC; elacridar; LAT1; l-Type
Keywords: ریفامپین; AFB; Acid Fast Bacilli; ATT; Anti-Tubercular Therapy; BCG; Bacillus Calmette Guerin; CI; Confidence Interval; DST; Drug Susceptibility Testing; HIV; Human Immunodeficiency Virus; IPT; Isoniazid Preventive Therapy; INH; Isoniazid; MDR-TB; Multi Drug Resist
Keywords: ریفامپین; Rifampicin; Tyrosinase inhibitor; Mechanism;
Keywords: ریفامپین; Poly(dl-lactide-co-glycolide); Rifampicin; Nanoparticle; Nanocomposite particle; Fine particle fraction; Amino acid;
Keywords: ریفامپین; Tuberculosis; Rifampicin; Nano-lipomer composites; Solid-state characterization; Simulated lung fluids;
Keywords: ریفامپین; Poly(dl-lactide-co-glycolide); Poly(l-lactide-co-glycolide); Glass transition temperature; Activation energy; Rifampicin; Nanoparticle;
Keywords: ریفامپین; Cost-effectiveness; Methicillin-resistant Staphylococcus aureus infection; Rifampicin; Linezolid; Quality-adjusted life-years; Trimethoprim-sulfamethoxazole;
Keywords: ریفامپین; Inflammation; Autophagy; Rifampicin; Rotenone; Microglia; Parkinson's Disease;
Keywords: ریفامپین; Controlled drug delivery; Molecular weight; Poly(ethylene carbonate); Protein release; Rifampicin; Surface erosion;
Keywords: ریفامپین; Tuberculosis; Rifampicin; Nanoparticle; MPEO-b-PCL; FRET; C120; coumarin 120; DACCA; 7-(diethylamino)-coumarin-3-carboxylic acid; DL; drug loading; DMEM; Dulbecco's modified Eagle's medium; EE; entrapment efficiency; FDA; fluorescein diacetate; FRET; För
Keywords: ریفامپین; antitubercular agents; isoniazid; rifampicin; pyrazinamide; oxidative stress; complementary therapies;
Keywords: ریفامپین; Poly(lactide-co-glycolide); Glass transition temperature; Rifampicin; Nanoparticle; Controlled release; Initial burst;
Keywords: ریفامپین; Bloodstream infection; Complicated bacteraemia; Device infection; Foreign body infection; Quality-of-care; Rifampicin;
Keywords: ریفامپین; meta-analysis; nontuberculous mycobacteria; systematic review; treatment outcome; 6MWT; 6-min walk test; AMX; amikacin; ATS; American Thoracic Society; AZT; azithromycin; BTS; British Thoracic Society; CLARI; clarithromycin; IDSA; Infectious Diseases Soci
Keywords: ریفامپین; Dictyostelium discoideum; Mycobacteria; Dormancy; Lipid droplet; Intracytosolic lipid inclusion; Perilipin; Tb; Tuberculosis; Mtb; Mycobacterium tuberculosis; FAs; fatty acids; TAG; striacylglycerols; LDs; lipid droplets; HCV; hepatitis C virus; ILIs; int
Keywords: ریفامپین; TB; tuberculosis; MTB; Mycobacterium tuberculosis; MDR-TB; multi-drug resistant tuberculosis; XDR-TB; extensively drug resistant tuberculosis; TDR-TB; totally drug resistant tuberculosis; INH; isoniazid; WHO; World Health Organization; RIF; rifampicin; PZ
Keywords: ریفامپین; Amylose; Acetylation; Rifampicin; Inclusion complexes; Drug delivery system;
Keywords: ریفامپین; Lactose; Nanoparticle; Polyvinylpyrrolidone; Pulmonary inhalation; Rifampicin;
Keywords: ریفامپین; DCA; deoxycholic acid; βMCA; β-muricholic acid; CA; cholic acid; CDCA; chenodeoxycholic acid; HDCA; hyodeoxycholic acid; ID; iron depletion; Rif; rifampicin; TUDCA; tauroursodeoxycholic acid; TCDCA; taurochenodeoxycholic acid; TDCA; taurodeoxycholic a
Keywords: ریفامپین; Drug delivery; Crystalline solid dispersion; Zwitterion; Rifampicin; Wetting; Dissolution rate; Solid-state properties;
Recent advancements in the development of anti-tuberculosis drugs
Keywords: ریفامپین; ADRs; adverse drug reactions; AG; arabinogalactan; AhpE; alkylhydroperoxide reductase E; Alr; d-alanine racemase; AMP; adenosine monophosphate; AnPRT; anthranilate phosphoribosyltransferase; ATP; adenosine triphosphate; BTZ; benzothiazinone; CADD; compute
Keywords: ریفامپین; Tuberculosis; Multidrug-resistant; Directly observed therapy; Rifampicin; Compliance; Thrombocytopenia
Keywords: ریفامپین; Rifampicin; Isoniazid; Mycobacterium tuberculosis; Resistance; Myanmar
Keywords: ریفامپین; Tuberculous meningitis; Rifampicin; Pharmacokinetics; Tolerability; Indonesia;
Keywords: ریفامپین; Rifampicin; Pharmacokinetics; Pharmacodynamics; Staphylococcus aureus
Keywords: ریفامپین; Neurobrucellosis; Rifampicin; Co-trimoxazoleNeurobrucellose; Rifampicine; Co-trimoxazole
Keywords: ریفامپین; Ceftaroline; Daptomycin; Linezolid; Rifampicin; 25-O-Desacetylrifampicin
Keywords: ریفامپین; Antibiotics; Capillary electrophoresis; Chiral selector; Enantioseparation; Rifampicin;
Keywords: ریفامپین; TB; tuberculosis; Mtb; Mycobacterium tuberculosis; AMP; antimicrobial peptide; PG; peptidoglycan; AG; arabinogalactan; MM; mycomembrane; TDM; trehalose dimycolate; TMM; trehalose monomycolate; PIM; phosphatidylinositol-mannosides; PDIM; phthiocerol dimyco
Keywords: ریفامپین; Lipid nanoparticles; Polymer nanoparticles; Inhaled drug delivery; Rifampicin; Poly(vinyl alcohol); Controlled drug release; Dissolution;
Keywords: ریفامپین; Multidrug-resistant; Mycobacterium tuberculosis; Mutation; Isoniazid; Rifampicin; Multifarmacorresistente; Mycobacterium tuberculosis; Mutación; Isoniazida; Rifampicina;